[go: up one dir, main page]

DK1128829T3 - Kombination af riluzol og alfa-tocopherol - Google Patents

Kombination af riluzol og alfa-tocopherol

Info

Publication number
DK1128829T3
DK1128829T3 DK99972101T DK99972101T DK1128829T3 DK 1128829 T3 DK1128829 T3 DK 1128829T3 DK 99972101 T DK99972101 T DK 99972101T DK 99972101 T DK99972101 T DK 99972101T DK 1128829 T3 DK1128829 T3 DK 1128829T3
Authority
DK
Denmark
Prior art keywords
combination
riluzole
tocopherol
alpha
benzothiazole
Prior art date
Application number
DK99972101T
Other languages
English (en)
Inventor
Michel Dib
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1128829T3 publication Critical patent/DK1128829T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
DK99972101T 1998-11-13 1999-11-09 Kombination af riluzol og alfa-tocopherol DK1128829T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814250A FR2785808B1 (fr) 1998-11-13 1998-11-13 Association riluzole et alpha-tocopherol
PCT/FR1999/002753 WO2000028992A1 (fr) 1998-11-13 1999-11-09 Association riluzole et alpha-tocopherol

Publications (1)

Publication Number Publication Date
DK1128829T3 true DK1128829T3 (da) 2005-08-29

Family

ID=9532674

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99972101T DK1128829T3 (da) 1998-11-13 1999-11-09 Kombination af riluzol og alfa-tocopherol

Country Status (23)

Country Link
US (2) US6642262B2 (da)
EP (1) EP1128829B1 (da)
JP (1) JP4693241B2 (da)
KR (1) KR100641472B1 (da)
CN (1) CN1177587C (da)
AT (1) ATE295168T1 (da)
AU (1) AU776242B2 (da)
BR (1) BR9915292A (da)
CA (1) CA2350671C (da)
CZ (1) CZ298808B6 (da)
DE (1) DE69925301T2 (da)
DK (1) DK1128829T3 (da)
EA (1) EA003671B1 (da)
ES (1) ES2239858T3 (da)
FR (1) FR2785808B1 (da)
HK (1) HK1041220B (da)
HU (1) HU226067B1 (da)
IL (1) IL142708A0 (da)
NO (1) NO328349B1 (da)
PT (1) PT1128829E (da)
TR (1) TR200101346T2 (da)
WO (1) WO2000028992A1 (da)
ZA (1) ZA200103810B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786101B1 (fr) * 1998-11-24 2002-07-05 Aventis Laboratoire Utilisation de la nicergoline dans le traitement de la spasticite
WO2007046347A1 (ja) * 2005-10-18 2007-04-26 Ono Pharmaceutical Co., Ltd. 筋萎縮性側索硬化症患者の運動神経保護用医薬
US20070099156A1 (en) * 2005-10-28 2007-05-03 Jeff Wagner Self-etching dental primer compositions and methods and systems utilizing such compositions
FR2957077B1 (fr) * 2010-03-02 2012-04-13 Univ Dauvergne Clermont I Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux
WO2014145776A2 (en) * 2013-03-15 2014-09-18 Baylor College Of Medicine Msp and its receptors in the therapy of amyotrophic lateral sclerosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688138B1 (fr) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
US5843641A (en) * 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
US6380252B1 (en) * 1996-07-05 2002-04-30 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
US5780489A (en) * 1996-08-21 1998-07-14 Brooks; Benjamin Rix Method for treating amyotrophic lateral sclerosis
JP3889844B2 (ja) * 1997-02-10 2007-03-07 龍兒 梶 筋萎縮性側索硬化症治療剤
FR2782008B1 (fr) * 1998-08-07 2003-04-25 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique

Also Published As

Publication number Publication date
BR9915292A (pt) 2001-08-07
EP1128829A1 (fr) 2001-09-05
NO20012308L (no) 2001-05-10
CZ298808B6 (cs) 2008-02-06
JP2002529506A (ja) 2002-09-10
HK1041220A1 (en) 2002-07-05
ATE295168T1 (de) 2005-05-15
WO2000028992A1 (fr) 2000-05-25
EP1128829B1 (fr) 2005-05-11
NO328349B1 (no) 2010-02-01
CA2350671A1 (fr) 2000-05-25
HUP0105301A2 (hu) 2002-05-29
CN1326348A (zh) 2001-12-12
DE69925301D1 (de) 2005-06-16
HU226067B1 (en) 2008-04-28
KR20010080407A (ko) 2001-08-22
HUP0105301A3 (en) 2006-07-28
US20030125363A1 (en) 2003-07-03
CZ20011561A3 (cs) 2001-08-15
DE69925301T2 (de) 2006-01-26
HK1041220B (zh) 2005-07-22
PT1128829E (pt) 2005-07-29
US6642262B2 (en) 2003-11-04
AU776242B2 (en) 2004-09-02
KR100641472B1 (ko) 2006-10-31
US20020019426A1 (en) 2002-02-14
AU1165500A (en) 2000-06-05
CN1177587C (zh) 2004-12-01
EA003671B1 (ru) 2003-08-28
NO20012308D0 (no) 2001-05-10
IL142708A0 (en) 2002-03-10
EA200100530A1 (ru) 2001-10-22
TR200101346T2 (tr) 2002-05-21
JP4693241B2 (ja) 2011-06-01
ES2239858T3 (es) 2005-10-01
FR2785808A1 (fr) 2000-05-19
CA2350671C (fr) 2010-05-04
FR2785808B1 (fr) 2002-12-06
ZA200103810B (en) 2002-08-12

Similar Documents

Publication Publication Date Title
NO20072142L (no) Mellomprodukter for fremstilling av heterocyklylalkylpiperidinderivater og forbindelser for fremstilling av disse
DK1214936T3 (da) Anvendelse af thiazolidin- eller pyrrolidinderivater af aminosyrer som antihyperglykæmiske midler
DK0797439T3 (da) Anvendelse af pramipexol som et neurobeskyttende middel
DK1336605T3 (da) Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X
NO960393D0 (no) Heterosykliske fenylforbindelser som COX-2-inhibitorer
BR0215405A (pt) Composições e processos de uso de collajolie
DK1288206T3 (da) Substituerede benzensulfonamidderivater som prolægemidler af COX-2-inhibitorer
DK0789578T3 (da) Inhibitorer af multikatalytisk protease
RS50071B (sr) Novi oblik soli pantoprazola
FR2848116B1 (fr) Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
NO20043107L (no) Bronnsementeringsbestanddeler for kalde omgivelser
DK1128829T3 (da) Kombination af riluzol og alfa-tocopherol
ES2168816T3 (es) Cemento de inyeccion que contiene inhibidores de la corrosion.
SV1998000088A (es) Compuestos farmaceuticos
SE9303060L (sv) Löstagbar stoppanordning
DK1131273T3 (da) 1,4-Diaryl-2-fluor-1-buten-3-olforbindelser og deres anvendelse til fremstilling af 1,4-diaryl-2-fluor-1,3-butadien- og 1,4-diaryl-2-fluor-2-butenforbindelser
SE9301401D0 (sv) Laasskruv jaemte skaerhaallaranordning
ECSP982785A (es) Nuevos compuestos de tetrahidroizoquinoleinil- carboxamida, de formula (i) y procedimiento para su obtencion
SE9302990D0 (sv) Anordning vid markberedning
ECSP972052A (es) Quinoxalinadionas
ID18481A (id) 2-(3,5-difluorofenil)-3-(4-metilsulfonil)fenil)-2-siklopenten-1-on yang berguna sebagai inhibitor cox-2
SE9103040L (sv) Saekerhetsfodral
KR950019590U (ko) 임의 위치고정이 가능한 축커플링
IT1303825B1 (it) Corredo di strumenti per microchirurgia oftalmica.
ES1042619Y (es) Pieza para la proteccion de los huesos metatarsianos.